Franklin Resources’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.98M	Sell	523,281 -46,908	-8%	-$364K	﹤0.01%	1522
2025 Q4	$4.45M	Buy	570,189 +104,851	+23%	+$758K	﹤0.01%	1449
2025 Q3	$3.53M	Buy	465,338 +71,453	+18%	+$595K	﹤0.01%	1572
2025 Q2	$3.53M	Buy	393,885 +69,490	+21%	+$647K	﹤0.01%	1496
2025 Q1	$2.43M	Buy	324,395 +62,013	+24%	+$500K	﹤0.01%	1616
2024 Q4	$1.97M	Sell	262,382 -1,366	-0.5%	-$10.4K	﹤0.01%	1739
2024 Q3	$1.97M	Buy	263,748 +168,790	+178%	+$1.28M	﹤0.01%	1751
2024 Q2	$587K	Buy	94,958 +18,031	+23%	+$99.5K	﹤0.01%	2159
2024 Q1	$391K	Buy	+76,927	New	+$433K	﹤0.01%	2362
2023 Q1	–	Sell	-14,414	Closed	-$165K	–	2318
2022 Q4	$165K	Buy	+14,414	New	+$180K	﹤0.01%	2039
2016 Q2	–	Sell	-1,658,217	Closed	-$4.69M	–	1499
2016 Q1	$4.69M	Hold	1,658,217	–	–	﹤0.01%	1112
2015 Q4	$17.1M	Buy	1,658,217 +245,400	+17%	+$2.44M	0.01%	887
2015 Q3	$16.1M	Buy	1,412,817 +664,098	+89%	+$8.86M	0.01%	907
2015 Q2	$11.2M	Buy	+748,719	New	+$8.51M	0.01%	1014